GINWA ENTERPRISE (GROUP) INC. — Investor Relations & Filings
About GINWA ENTERPRISE (GROUP) INC.
Ginwa Enterprise (Group) Inc. operates as a diversified conglomerate focused on the research, development, manufacturing, and distribution of medical products. The company's portfolio includes traditional Chinese medicines, chemical drugs, and biological preparations targeting therapeutic areas such as cardiovascular health, anti-infectives, and digestive disorders. In addition to its medical operations, the group is involved in high-tech development, real estate, and strategic investment activities. The organization prioritizes technological innovation and adheres to rigorous quality control standards across its production facilities. It serves a broad market base, focusing on the modernization of traditional medicinal practices and the integration of advanced biotechnology into its product offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 金花企业（集团）股份有限公司2025年度募集资金年度存放、管理与实际使用情况鉴证报告 | 2026-04-28 | Chinese | |
| 金花企业（集团）股份有限公司2025年度审计报告 | 2026-04-28 | Chinese | |
| 金花企业（集团）股份有限公司董事会议事规则 | 2026-04-28 | Chinese | |
| 金花企业(集团)股份有限公司关于前期会计差错更正后的财务报表及附注 | 2026-04-28 | Chinese | |
| 金花企业（集团）股份有限公司2025年年度报告 | 2026-04-28 | Chinese | |
| 金花企业（集团）股份有限公司关于召开2025年年度股东会的通知 | 2026-04-28 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40286544 | 金花企业（集团）股份有限公司2025年度募集资金年度存放、管理与实际使用情况鉴证报告 | 2026-04-28 | Chinese | ||
| 40286453 | 金花企业（集团）股份有限公司2025年度审计报告 | 2026-04-28 | Chinese | ||
| 40286191 | 金花企业（集团）股份有限公司董事会议事规则 | 2026-04-28 | Chinese | ||
| 40286182 | 金花企业(集团)股份有限公司关于前期会计差错更正后的财务报表及附注 | 2026-04-28 | Chinese | ||
| 40286173 | 金花企业（集团）股份有限公司2025年年度报告 | 2026-04-28 | Chinese | ||
| 40286127 | 金花企业（集团）股份有限公司关于召开2025年年度股东会的通知 | 2026-04-28 | Chinese | ||
| 40286120 | 金花企业（集团）股份有限公司董事会提名委员会关于公司第十届董事会换届选举相关事项的审核意见 | 2026-04-28 | Chinese | ||
| 40286106 | 金花企业（集团）股份有限公司独立董事2025年度述职报告（吴雅婕） | 2026-04-28 | Chinese | ||
| 40286090 | 金花企业（集团）股份有限公司董事会关于独立董事独立性自查情况的专项意见 | 2026-04-28 | Chinese | ||
| 40286084 | 金花企业（集团）股份有限公司关于更换持续督导保荐代表人的公告 | 2026-04-17 | Chinese | ||
| 40286083 | 金花企业（集团）股份有限公司关于收到中国证券监督管理委员会陕西监管局《行政监管措施决定书》的公告 | 2026-04-10 | Chinese | ||
| 40286081 | 金花企业（集团）股份有限公司关于集中竞价减持已回购股份的进展公告 | 2026-04-03 | Chinese | ||
| 40286075 | 金花企业（集团）股份有限公司关于公司进行融资租赁的公告 | 2026-03-17 | Chinese | ||
| 40286068 | 金花企业（集团）股份有限公司关于集中竞价减持已回购股份的进展公告 | 2026-03-02 | Chinese | ||
| 40286060 | 金花企业（集团）股份有限公司关于首次集中竞价减持已回购股份的进展公告 | 2026-02-13 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
GINWA ENTERPRISE (GROUP) INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56468/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56468 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56468 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56468 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56468}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GINWA ENTERPRISE (GROUP) INC. (id: 56468)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.